Acid inactivation of prions: efficient at elevated temperature or high acid concentration.

Scrapie prion rods isolated from hamster and non-infectious aggregates of the corresponding recombinant protein rPrP(90-231) were incubated with hydrochloric acid. The amount of PrP and of infectivity that survived incubation in HCl at varying times, acid concentrations and temperatures was quantified by Western blot densitometry and bioassays, respectively. Prion rods and rPrP aggregates showed similar HCl hydrolysis kinetics of PrP, indicating structural homology. For 1 M HCl and 25 degrees C, the rate of PrP hydrolysis follows first-order kinetics at 0.014 h(-1); the rate of infectivity inactivation is 0.54 h(-1). Hydrolysis for 1 h at 25 degrees C was only slightly proportional to HCl concentration up to 5 M, but complete loss of infectivity and PrP reduction to <2 % was observed at 8 M HCl. The temperature dependence of unhydrolysed PrP, as well as infectivity at 1 M HCl for 1 h, showed a slight decrease up to 45 degrees C, but a sigmoidal decrease by several orders of magnitude at higher temperatures. The slow hydrolysis of PrP and inactivation of infectivity by acid treatment at room temperature are attributed to solvent inaccessibility of prion rods and rPrP aggregates, respectively. The more effective hydrolysis and inactivation at temperatures above 45 degrees C are interpreted as thermally induced disaggregation with an activation energy of 50-60 kJ mol(-1). Most importantly, infectivity was always inactivated faster or to a higher extent than PrP was hydrolysed at several incubation times, HCl concentrations and temperatures.

[1]  James E. Cleaver,et al.  Search for a Prion-Specific Nucleic Acid , 2005, Journal of Virology.

[2]  F. Cohen,et al.  Synthetic Mammalian Prions , 2004, Science.

[3]  B. Chesebro,et al.  A View from the Top--Prion Diseases from 10,000 Feet , 2003, Science.

[4]  A. Aguzzi,et al.  Prion diseases: Cannibals and garbage piles , 2003, Nature.

[5]  S. Prusiner,et al.  Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. , 2003, Clinics in laboratory medicine.

[6]  I. Mcconnell,et al.  Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents. , 2002, The Journal of general virology.

[7]  R. Somerville,et al.  Characterization of Thermodynamic Diversity between Transmissible Spongiform Encephalopathy Agent Strains and Its Theoretical Implications* , 2002, The Journal of Biological Chemistry.

[8]  David A Agard,et al.  Structural studies of the scrapie prion protein by electron crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Taylor,et al.  Gastric Acidity Protects Mice Against Prion Infection? , 2002, Scandinavian journal of gastroenterology.

[10]  S. Prusiner,et al.  Shattuck lecture--neurodegenerative diseases and prions. , 2001, The New England journal of medicine.

[11]  D. Riesner,et al.  Heat stability of prion rods and recombinant prion protein in water, lipid and lipid-water mixtures. , 2001, The Journal of general virology.

[12]  S. Prusiner,et al.  Structural Intermediates in the Putative Pathway from the Cellular Prion Protein to the Pathogenic Form , 2001, Biological chemistry.

[13]  F. Cohen,et al.  Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein. , 2000, Journal of structural biology.

[14]  D. Strack Microcharacterization of Proteins (2nd edn): edited by R. Kellner, F. Lottspeich, H.E. Meyer, Wiley-VCH, Weinheim, XXI+325 pp. ISBN: 3-527-30084-8, DM 158.00. , 1999 .

[15]  J. Darbord Inactivation of prions in daily medical practice. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  D. Riesner,et al.  Prion Rods Contain an Inert Polysaccharide Scaffold , 1999, Biological chemistry.

[17]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[18]  D. Kirsch,et al.  Prion Rods Contain Small Amounts of Two Host Sphingolipids as Revealed by Thin-Layer Chromatography and Mass Spectrometry , 1998, Biological chemistry.

[19]  M. Beekes,et al.  Highly infectious purified preparations of disease-specific amyloid of transmissible spongiform encephalopathies are not devoid of nucleic acids of viral size. , 1997, Intervirology.

[20]  M. Beekes,et al.  Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. , 1996, The Journal of general virology.

[21]  F. Cohen,et al.  High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. , 1996, Biochemistry.

[22]  S. Prusiner,et al.  Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity , 1996, Journal of virology.

[23]  W. Schlote,et al.  Tissue Handling in Suspected Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) , 1995, Brain pathology.

[24]  F. Lottspeich,et al.  Microcharacterization of Proteins , 1994 .

[25]  R. Race,et al.  Comparative analysis of scrapie agent inactivation methods. , 1993, Journal of virological methods.

[26]  C. Weissmann,et al.  A 'unified theory' of prion propagation , 1991, Nature.

[27]  S. Prusiner,et al.  Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis , 1991, Journal of virology.

[28]  P. Liberski,et al.  Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. , 1990, The Journal of infectious diseases.

[29]  H. Wiśniewski,et al.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins , 1987, Journal of virology.

[30]  T. Sklaviadis,et al.  Evidence suggesting that PrP is not the infectious agent in Creutzfeldt‐Jakob disease. , 1987, The EMBO journal.

[31]  P. Brown,et al.  Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. , 1986, The Journal of infectious diseases.

[32]  S. Prusiner,et al.  Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.

[33]  S. Prusiner,et al.  A protease-resistant protein is a structural component of the Scrapie prion , 1983, Cell.

[34]  D. Taylor,et al.  Disinfection studies with two strains of mouse-passaged scrapie agent Guidelines for Creutzfeldt-Jakob and related agents , 1983, Journal of the Neurological Sciences.

[35]  S. Prusiner,et al.  Further purification and characterization of scrapie prions. , 1982, Biochemistry.

[36]  S. Prusiner,et al.  Viroids and prions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Prusiner Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[38]  S. Prusiner,et al.  Measurement of the scrapie agent using an incubation time interval assay , 1982, Annals of neurology.

[39]  S. Prusiner,et al.  Thiocyanate and hydroxyl ions inactivate the scrapie agent. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Morris,et al.  Scrapie in Mice , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[41]  A. Dawson,et al.  SCRAPIE IN MICE. THE STABILITY OF THE AGENT TO VARIOUS SUSPENDING MEDIA, PH AND SOLVENT EXTRACTION. , 1965, Research in veterinary science.

[42]  D. Taylor,et al.  Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie , 2005, Archives of Virology.

[43]  D Riesner,et al.  The prion theory: background and basic information. , 2001, Contributions to microbiology.

[44]  J. Collinge Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[45]  H. Kretzschmar,et al.  Prionen und Prionkrankheiten , 2001 .

[46]  D. Taylor Inactivation of transmissible degenerative encephalopathy agents: A review. , 2000, Veterinary journal.

[47]  L. Manuelidis Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. , 1997, Journal of neurovirology.

[48]  B. Chesebro Transmissible spongiform encephalopathies: scrapie, BSE and related human disorders. , 1991, Current topics in microbiology and immunology.

[49]  P. Brown,et al.  The human spongiform encephalopathies: kuru, Creutzfeldt-Jakob disease, and the Gerstmann-Sträussler-Scheinker syndrome. , 1991, Current topics in microbiology and immunology.

[50]  S. Prusiner,et al.  IMMUNOAFFINITY PURIFICATION AND NEUTRALIZATION OF SCRAPIE PRIONS , 1988 .